November 20, 2023
Santen Pharmaceutical said on November 17 that it has earned European regulatory approval for Catiolanze (cationic emulsion of latanoprost 50 μg/mL) as a new treatment for glaucoma and ocular hypertension. The European Commission approved the drug for lowering intraocular pressure...read more